TS-037724 — Small molecules for targeted treatment of triple negative breast cancer and other aggressive phenotypes.
Breast cancer is a heterogeneous group of tumors which can be subdivided based on histopathological features, genetic alterations, and gene-expression profiles. Approximately 50-60% of all breast cancer patients and two-thirds of postmenopausal breast cancer patients have estrogen receptor positiv…
